- Case Report
- Open Access
Laparoscopic liver resection for liver metastasis of leiomyosarcoma of the thigh: a case report
Surgical Case Reports volume 8, Article number: 47 (2022)
Although there is no established treatment strategy for liver metastasis of leiomyosarcoma, liver resection has been reported to be effective in some cases. However, almost all liver resections performed for liver metastasis of primary leiomyosarcoma are reported to be open resections, and there are few reports of liver resection performed by laparoscopy. Here, we report a case of laparoscopic liver resection for liver metastasis of a leiomyosarcoma in the right thigh.
An 80-year-old man was diagnosed with leiomyosarcoma of the right thigh with liver metastasis. The primary tumor was first resected, and he was discharged on the 25th postoperative day. Four months after primary tumor resection, a laparoscopic right posterior sectionectomy was performed. There were no postoperative complications, and the patient was discharged on the 11th postoperative day with a histopathological diagnosis of liver metastasis of leiomyosarcoma and negative resection margins. Currently, 9 months have passed since the resection of the primary tumor, and 5 months have passed since the laparoscopic liver resection; there is no recurrence.
The liver metastasis of leiomyosarcoma was successfully removed, with good short-term outcomes after the laparoscopic liver resection. Laparoscopic liver resection seems to be effective for liver metastasis of leiomyosarcoma, which is characterized by a high recurrence rate after surgery. However, more case studies may be necessary to examine the effectiveness and long-term results of laparoscopic liver resection for the treatment of liver metastasis of leiomyosarcoma.
Leiomyosarcoma is one of the most common histological types of soft-tissue sarcomas, accounting for 5–10% of all cases . It most commonly occurs in the extremities, particularly the lower extremities, retroperitoneum, abdomen/pelvis, and trunk [2, 3]. It has been estimated that 25–40% of patients with soft-tissue sarcoma develop metastases despite appropriate local treatment [4, 5]. The most common site of metastasis, either during the first recurrence or subsequent disease progression, is the lungs, followed by the liver and soft tissue. Less common sites of metastasis are the bones, soft tissue of the chest wall with the exception of the lung parenchyma, and abdomen or retroperitoneum [2, 3].
There is no established treatment for liver metastasis of leiomyosarcoma, but liver resection has been reported to be effective [4,5,6,7,8,9]. The recurrence rate of leiomyosarcoma is high, even after surgical resection. However, there are reports that re-liver resection is effective . In most previous surgical studies, open surgery was conducted for liver metastases of primary leiomyosarcomas in the extremities; only one study has reported laparoscopic liver resection as a treatment for metachronous liver metastasis . Herein, we report a case of laparoscopic liver resection for synchronous liver metastasis from a primary leiomyosarcoma of the extremities.
An 80-year-old man presented to the hospital with an enlarged mass in his right thigh. His medical history included hypertension and diabetes mellitus; however, his general condition was good. Upon physical examination, an 18-cm mass was palpated in his right thigh. Laboratory blood test findings were normal. Indocyanine green retention at 15 min was 4.3% and technetium-99 m diethylenetriaminepentaacetic acid galactosyl human serum albumin revealed a blood clearance index (HH15; uptake ratio of the heart at 15 min to that at 3 min) of 0.535 and receptor index (LHL15; uptake ratio of the liver to the liver plus heart at 15 min) of 0.933, indicating good liver function. Whole-body computed tomography (CT) revealed a 25-mm mass with heterogeneous contrast effect in the right thigh and a low-density mass in segment 7 of the liver (S7). T2-weighted magnetic resonance imaging (MRI) revealed a 25-mm solid tumor with a high-intensity signal at the right medial thigh, which was suggestive of a soft-tissue sarcoma. A gadolinium-ethoxybenzyl-diethylenetriamine pentaacetic acid (EOB) MRI revealed decreased EOB uptake in the liver S7. Moreover, 18F-fluorodeoxyglucose-positron emission tomography CT revealed fluorodeoxyglucose accumulation with a maximal standardized uptake value of 12.3 in the liver S7, which was suggestive of synchronous metastasis (Fig. 1). There were no other distant metastatic lesions. A percutaneous needle biopsy was performed from the soft tissue mass of the right thigh, resulting in a histopathological diagnosis of leiomyosarcoma. Subsequently, a CT-guided needle biopsy was performed on the liver mass, resulting in a histopathological diagnosis of liver metastasis of leiomyosarcoma. Resection of the primary tumor was planned to be performed first, followed by liver resection. The right thigh tumor was resected, along with a portion of the vastus medialis. On the 14th postoperative day, antibiotics were administered owing to wound redness and elevated levels of inflammatory markers. Thereafter, the patient’s condition progressed without any problems, and he was discharged on the 25th postoperative day. A histopathological diagnosis of leiomyosarcoma was made based on the presence of atypical spindle cells with numerous mitotic figures [42 mitoses/10 high-power fields] (Fig. 2A) in addition to necrosis in more than 50% of the tumor volume, which resulted in classification as French Federation of Cancer Centers grade III. Immunohistochemical detection of desmin (Fig. 2B) and α-SMA (Fig. 2C) as well as a Ki-67 labeling index of up to 60% (Fig. 2D) confirmed the diagnosis. Four months after primary tumor resection and confirmation that the liver was the sole site of metastasis along with no change in its size based on imaging findings, laparoscopic right posterior sectionectomy was performed. The surgical time was 5 h 14 min, and blood loss volume was 80 mL. There were no postoperative complications, and the patient was discharged on the 11th postoperative day. The histopathological diagnosis was liver metastasis of leiomyosarcoma with negative resection margins (Fig. 3). Currently, 9 months have passed since the resection of the primary tumor, and 5 months have passed since laparoscopic liver resection, and there is no tumor recurrence. We observed the patient through periodic follow-ups.
We performed metachronous laparoscopic liver resection for synchronous liver metastasis of primary leiomyosarcoma of the right thigh. Only one case of laparoscopic liver resection for liver metastasis of leiomyosarcoma was reported previously .
Although various treatment modalities have been investigated, liver resection is considered to be an effective treatment for liver metastases derived from leiomyosarcoma. Liver resection for liver metastases derived from leiomyosarcoma is reported to result in a 5-year overall survival (OS) of 12–51.8% and a median survival time (MST) of 11–77 months [4,5,6, 8, 9, 11,12,13,14,15] (Table 1). Other treatment options are systemic chemotherapy, chemoembolization, radiofrequency ablation, and liver resection [4,5,6, 8, 9, 16,17,18,19,20,21]. However, the response rate of liver metastases of leiomyosarcoma to chemotherapy is low, with response durations of only a few weeks to months [22, 23], and chemoembolization is not effective for hypovascular liver metastases such as the present case . For these reasons, liver resection was elected as the most appropriate treatment option for the present case. Partial liver resection and posterior sectionectomy were considered for this case; however, posterior sectionectomy was indicated due to reports that remnant liver ischemia after liver resection can result in a higher recurrence rate and worse survival outcomes in cases of liver metastases from a malignant tumor . At the same time, the patient’s liver function was good enough to tolerate the posterior sectionectomy, which was safely performed as a laparoscopic procedure without any postoperative complications.
In the present case, the patient had simultaneous liver metastases, and went through two-staged surgeries, with liver resection performed 4 months after resection of primary tumor. According to Marudanayagam et al., there was no significant difference in survival outcome after liver resection between patients with synchronous versus metachronous liver metastases from soft-tissue sarcomas . However, the appropriate time for surgery and a comparison of the effectiveness of the one-stage or two-stage surgical approaches for synchronous liver metastases from leiomyosarcomas has not been established and requires further research and accumulation of cases. For other malignancies, there is no clear difference between synchronous and metachronous resection in cases of synchronous colorectal cancer liver metastases [26, 27].
According to previous reports regarding liver resection for liver metastases of leiomyosarcomas, in almost all cases, only open liver resection performed [4,5,6, 8, 9, 11,12,13, 28], and only a few cases involving laparoscopic liver resection have been reported . Owing to advances in surgical instruments and understanding, the indications for laparoscopic liver resection are expanding to include a wide range of liver tumors , and this method is now practiced in many countries. Several reports suggest that laparoscopic liver resection leads to lower intraoperative blood loss than does open liver resection due to the magnified field of view and reduced bleeding from the hepatic veins because of insufflation pressure and reduced adhesions [30,31,32]. In addition, it has been reported that postoperative complications such as ascites were less common in laparoscopic liver resection than in open liver resection because of the smaller wound and decreased mobilization associated with laparoscopic surgery compared to those associated with surgery for hepatocellular carcinoma [33, 34]. In hepatocellular carcinoma, laparoscopic liver resection and open liver resection result in similar long-term outcomes; OS and recurrence-free survival have been found to be equivalent between the two methods [32, 35]. In addition, no studies have specifically disagreed with the use of laparoscopic liver resection in malignant liver tumors, such as hepatocellular carcinoma and colorectal cancer liver metastases. Currently, few reports regarding laparoscopic liver resection for liver metastasis of leiomyosarcoma exists; however; the number of reports is expected to increase in the future, and survival outcomes should be thoroughly investigated.
Leiomyosarcoma liver metastasis is characterized by a high recurrence rate of approximately 43.7–88% after surgery [4,5,6, 28]. Rehders et al. performed re-liver resection in two of four patients with hepatic recurrence after liver resection for liver metastasis of leiomyosarcoma. The MST for patients who underwent re-liver resection was 76 months, while the MST for patients who did not undergo re-liver resection was 26 months. They showed that re-resection of recurrent intrahepatic lesions led to a significantly better prognosis than that with non-re-resection . Moreover, postoperative adhesions are less likely to form after laparoscopic liver resection than after open liver resection due to decreased mobilization during the laparoscopic procedure [36, 37]. The possibility of re-liver resection should be considered for this class of tumor owing to their high rate of recurrence associated with it. Therefore, laparoscopic liver resection, which results in fewer adhesions and a lower rate of complications, seems to be a more effective method for the treatment of liver metastasis of leiomyosarcoma.
In conclusion, we present the case of a patient in whom the liver metastasis of a leiomyosarcoma was successfully removed by laparoscopic liver resection with good short-term outcomes. Our findings suggest that laparoscopic liver resection is an effective treatment approach for liver metastasis of leiomyosarcoma, which have a high recurrence rate but are effectively treated by re-liver resection. However, because this case had a postoperative observation period of only 7 months, more case studies are warranted to examine the long-term effectiveness of laparoscopic liver resection for the treatment of liver metastasis of leiomyosarcoma.
Availability of data and materials
Magnetic resonance imaging
Gadolinium-ethoxybenzyl-diethylenetriamine pentaacetic acid
Median survival time
Complete surgical resection
Mestiri S, Elghali MA, Bourigua R, Abdessayed N, Nasri S, Amine BA, et al. Soft tissue leiomyosarcoma—diagnostics, management, and prognosis: data of the registry cancer of the center of Tunisia. Rare Tumors. 2019;11:2036361318820171. https://doi.org/10.1177/2036361318820171.
Gladdy RA, Qin LX, Moraco N, Agaram NP, Brennan MF, Singer S. Predictors of survival and recurrence in primary leiomyosarcoma. Ann Surg Oncol. 2013;20:1851–7. https://doi.org/10.1245/s10434-013-2876-y.
Wile AG, Evans HL, Romsdahl MM. Leiomyosarcoma of soft tissue: a clinicopathologic study. Cancer. 1981;48:1022–32. https://doi.org/10.1002/1097-0142(19810815)48:4%3c1022::aid-cncr2820480429%3e3.0.co;2-5.
Marudanayagam R, Sandhu B, Perera MTPR, Bramhall SR, Mayer D, Buckels JAC, et al. Liver resection for metastatic soft tissue sarcoma: an analysis of prognostic factors. Eur J Surg Oncol. 2011;37:87–92. https://doi.org/10.1016/j.ejso.2010.11.006.
Rehders A, Peiper M, Stoecklein NH, Alexander A, Boelke E, Knoefel WT, et al. Hepatic metastasectomy for soft-tissue sarcomas: is it justified? World J Surg. 2009;33:111–7. https://doi.org/10.1007/s00268-008-9777-4.
Dematteo RP, Shah A, Fong Y, Jarnagin WR, Blumgart LH, Brennan MF. Results of hepatic resection for sarcoma metastatic to liver. Ann Surg. 2001;234:540–7.
Faraj W, El-Kehdy J, El Nounou GE, Deeba S, Fakih H, Jabbour M, et al. Liver resection for metastatic colorectal leiomyosarcoma: a single center experience. J Gastrointest Oncol. 2015;6:E70–6. https://doi.org/10.3978/j.issn.2078-6891.2015.044.
Lang H, Nussbaum KT, Kaudel P, Frühauf N, Flemming P, Raab R. Hepatic metastases from leiomyosarcoma: a single-center experience with 34 liver resections during a 15-year period. Ann Surg. 2000;231:500–5. https://doi.org/10.1097/00000658-200004000-00007.
Grimme FAB, Seesing MFJ, van Hillegersberg R, van Coevorden F, de Jong KP, Nagtegaal ID, et al. Liver resection for hepatic metastases from soft tissue sarcoma: a nationwide study. Dig Surg. 2019;36:479–86. https://doi.org/10.1159/000493389.
Fukui K, Takase N, Miyake T, Hisano K, Maeda E, Nishimura T, et al. Review of the literature laparoscopic surgery for metastatic hepatic leiomyosarcoma associated with smooth muscle tumor of uncertain malignant potential: case report. World J Hepatol. 2018;10:402–8. https://doi.org/10.4254/wjh.v10.i4.402.
Foster JH. Survival after liver resection for secondary tumors. Am J Surg. 1978;135:389–94. https://doi.org/10.1016/0002-9610(78)90072-7.
Groeschl RT, Nachmany I, Steel JL, Reddy SK, Glazer ES, de Jong MC, et al. Hepatectomy for noncolorectal non-neuroendocrine metastatic cancer: a multi-institutional analysis. J Am Coll Surg. 2012;214:769–77. https://doi.org/10.1016/j.jamcollsurg.2011.12.048.
Zhang F, Wang J. Clinical features of surgical resection for liver metastasis from extremity soft tissue sarcoma. Hepatogastroenterology. 2015;62:677–82.
Goumard C, Marcal LP, Wang WL, Somaiah N, Okuno M, Roland CL, et al. Long-term survival according to histology and radiologic response to preoperative chemotherapy in 126 patients undergoing resection of non-GIST sarcoma liver metastases. Ann Surg Oncol. 2018;25:107–16. https://doi.org/10.1245/s10434-017-6144-4.
Brudvik KW, Patel SH, Roland CL, Conrad C, Torres KE, Hunt KK, et al. Survival after resection of gastrointestinal stromal tumor and sarcoma liver metastases in 146 patients. J Gastrointest Surg. 2015;19:1476–83. https://doi.org/10.1007/s11605-015-2845-9.
Mizoshiri N, Shirai T, Terauchi R, Tsuchida S, Mori Y, Katsuyama Y, et al. Hepatic metastases from primary extremity leiomyosarcomas. Medicine (United States). 2018;97.
Jaques DP, Coit DG, Casper ES, Brennan MF. Hepatic metastases from soft-tissue sarcoma. J. B: Lippincott Publishers Company; 1995.
Grobmyer SR, Maki RG, Demetri GD, Mazumdar M, Riedel E, Brennan MF, et al. Neo-adjuvant chemotherapy for primary high-grade extremity soft tissue sarcoma. Ann Oncol. 2004;15:1667–72. https://doi.org/10.1093/annonc/mdh431.
Svarvar C, Böhling T, Berlin O, Gustafson P, Follerås G, Bjerkehagen B, et al. Clinical course of nonvisceral soft tissue leiomyosarcoma in 225 patients from the Scandinavian sarcoma group. Cancer. 2007;109:282–91. https://doi.org/10.1002/cncr.22395.
Okamoto M, Matsuoka M, Soma T, Arai R, Kato H, Harabayashi T, et al. Metastases of soft tissue sarcoma to the liver: a historical cohort study from a hospital-based cancer registry. Cancer Med. 2020;9:6159–65. https://doi.org/10.1002/cam4.3304.
Maeda T, Yugawa K, Kinjo N, Imai D, Sanefuji K, Kawata K, et al. Large surgically resected leiomyosarcoma of the liver: a case report. Surg Case Rep. 2020;6:168. https://doi.org/10.1186/s40792-020-00934-6.
Edmonson JH, Ryan LM, Blum RH, Brooks JS, Shiraki M, Frytak S, et al. Randomized comparison of doxorubicin alone versus ifosfamide plus doxorubicin or mitomycin, doxorubicin, and cisplatin against advanced soft tissue sarcomas. J Clin Oncol. 1993;11:1269–75. https://doi.org/10.1200/JCO.19184.108.40.2069.
Casper ES, Christman KL, Schwartz GK, Johnson B, Brennan MF, Bertino JR. Edatrexate in patients with soft tissue sarcoma. Activity in malignant fibrous histiocytoma. Cancer. 1993;72:766–70. https://doi.org/10.1002/1097-0142(19930801)72:3%3c766::aid-cncr2820720321%3e3.0.co;2-z.
Mavligit GM, Zukwiski AA, Ellis LM, Chuang VP, Wallace S. Gastrointestinal leiomyosarcoma metastatic to the liver. Durable tumor regression by hepatic chemoembolization infusion with cisplatin and vinblastine. Cancer. 1995;75:2083–8. https://doi.org/10.1002/1097-0142(19950415)75:8%3c2083::aid-cncr2820750809%3e3.0.co;2-h.
Yamashita S, Venkatesan AM, Mizuno T, Aloia TA, Chun YS, Lee JE, et al. Remnant liver ischemia as a prognostic factor for cancer-specific Survival after resection of colorectal liver metastases. JAMA Surg. 2017;152:e172986. https://doi.org/10.1001/jamasurg.2017.2986.
Adam R, de Gramont A, Figueras J, Kokudo N, Kunstlinger F, Loyer E, et al. Managing synchronous liver metastases from colorectal cancer: a multidisciplinary international consensus. Cancer Treat Rev. 2015;41:729–41. https://doi.org/10.1016/j.ctrv.2015.06.006.
Bismuth H, Castaing D, Traynor O. Surgery for synchronous hepatic metastases of colorectal cancer. Scand J Gastroenterol Suppl. 1988;149:144–9. https://doi.org/10.3109/00365528809096972.
Pawlik TM, Vauthey JN, Abdalla EK, Pollock RE, Ellis LM, Curley SA. Results of a single-center experience with resection and ablation for sarcoma metastatic to the liver. Arch Surg. 2006;141:537–43. https://doi.org/10.1001/archsurg.141.6.537.
Yoshida H, Taniai N, Yoshioka M, Hirakata A, Kawano Y, Shimizu T, et al. Current status of laparoscopic hepatectomy. J Nippon Med Sch. 2019;86:201–6. https://doi.org/10.1272/jnms.JNMS.2019_86-411.
Yin Z, Fan X, Ye H, Yin D, Wang J. Short- and long-term outcomes after laparoscopic and open hepatectomy for hepatocellular carcinoma: a global systematic review and meta-analysis. Ann Surg Oncol. 2013;20:1203–15. https://doi.org/10.1245/s10434-012-2705-8.
Takahara T, Wakabayashi G, Beppu T, Aihara A, Hasegawa K, Gotohda N, et al. Long-term and perioperative outcomes of laparoscopic versus open liver resection for hepatocellular carcinoma with propensity score matching: a multi-institutional Japanese study. J Hepatobiliary Pancreat Sci. 2015;22:721–7. https://doi.org/10.1002/jhbp.276.
Xiong JJ, Altaf K, Javed MA, Huang W, Mukherjee R, Mai G, et al. Meta-analysis of laparoscopic vs open liver resection for hepatocellular carcinoma. World J Gastroenterol. 2012;18:6657–68. https://doi.org/10.3748/wjg.v18.i45.6657.
Morise Z, Ciria R, Cherqui D, Chen KH, Belli G, Wakabayashi G. Can we expand the indications for laparoscopic liver resection? A systematic review and meta-analysis of laparoscopic liver resection for patients with hepatocellular carcinoma and chronic liver disease. J Hepato-Bil Pancreat Sci. 2015;22:342–52. https://doi.org/10.1002/jhbp.215.
Twaij A, Pucher PH, Sodergren MH, Gall T, Darzi A, Jiao LR. Laparoscopic vs open approach to resection of hepatocellular carcinoma in patients with known cirrhosis: systematic review and meta-analysis. World J Gastroenterol. 2014;20:8274–81. https://doi.org/10.3748/wjg.v20.i25.8274.
Sotiropoulos GC, Prodromidou A, Machairas N. Meta-analysis of laparoscopic vs open liver resection for hepatocellular carcinoma: the European experience. J BUON. 2017;22:1160–71.
Ha GW, Lee MR, Kim JH. Adhesive small bowel obstruction after laparoscopic and open colorectal surgery: a systematic review and meta-analysis. Am J Surg. 2016;212:527–36. https://doi.org/10.1016/j.amjsurg.2016.02.019.
Morise Z, Kawabe N, Kawase J, Tomishige H, Nagata H, Ohshima H, et al. Pure laparoscopic hepatectomy for hepatocellular carcinoma with chronic liver disease. World J Hepatol. 2013;5:487–95. https://doi.org/10.4254/wjh.v5.i9.487.
Ethics approval and consent to participate
Consent for publication
Written informed consent was obtained from the patient.
The authors declare that they have no competing interests.
Springer Nature remains neutral with regard to jurisdictional claims in published maps and institutional affiliations.
About this article
Cite this article
Tsuzaka, S., Asahi, Y., Kamiyama, T. et al. Laparoscopic liver resection for liver metastasis of leiomyosarcoma of the thigh: a case report. surg case rep 8, 47 (2022). https://doi.org/10.1186/s40792-022-01400-1
- Laparoscopic liver resection
- Liver metastasis of leiomyosarcoma
- Liver metastasis of leiomyosarcoma of the thigh